Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to $1000.0.

  • Palisade Bio's Depreciation & Amortization (CF) changed 0.0% to $1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $3000.0 for FY2024, which is 2500.0% down from last year.
  • Latest data reveals that Palisade Bio reported Depreciation & Amortization (CF) of $1000.0 as of Q3 2025, which was down 0.0% from $1000.0 recorded in Q2 2025.
  • Over the past 5 years, Palisade Bio's Depreciation & Amortization (CF) peaked at $2000.0 during Q4 2022, and registered a low of $1000.0 during Q1 2021.
  • For the 5-year period, Palisade Bio's Depreciation & Amortization (CF) averaged around $1166.7, with its median value being $1000.0 (2021).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first crashed by 9656.1% in 2021, then changed by 0.0% in 2022.
  • Quarter analysis of 5 years shows Palisade Bio's Depreciation & Amortization (CF) stood at $1000.0 in 2021, then surged by 100.0% to $2000.0 in 2022, then tumbled by 50.0% to $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025.
  • Its last three reported values are $1000.0 in Q3 2025, $1000.0 for Q2 2025, and $1000.0 during Q1 2025.